CSL (Atopic Dermatitis Candidate ASLAN004) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Asset Purch.

  • Financing Rounds
  • 1

CSL (Atopic Dermatitis Candidate ASLAN004) General Information

Description

Atopic dermatitis antibody intended to cure symptoms of allergy in dermatitis.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Parkville, Victoria
  • Australia
Primary Industry
Buildings and Property
Other Industries
Drug Discovery
Corporate Office
  • Parkville, Victoria
  • Australia

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

CSL (Atopic Dermatitis Candidate ASLAN004) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore CSL (Atopic Dermatitis Candidate ASLAN004)‘s full profile, request access.

Request a free trial

CSL (Atopic Dermatitis Candidate ASLAN004) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore CSL (Atopic Dermatitis Candidate ASLAN004)‘s full profile, request access.

Request a free trial

CSL (Atopic Dermatitis Candidate ASLAN004) FAQs

  • Where is CSL (Atopic Dermatitis Candidate ASLAN004) headquartered?

    CSL (Atopic Dermatitis Candidate ASLAN004) is headquartered in Parkville, Australia.

  • What industry is CSL (Atopic Dermatitis Candidate ASLAN004) in?

    CSL (Atopic Dermatitis Candidate ASLAN004)’s primary industry is Buildings and Property.

  • Is CSL (Atopic Dermatitis Candidate ASLAN004) a private or public company?

    CSL (Atopic Dermatitis Candidate ASLAN004) is a Private company.

  • What is the current valuation of CSL (Atopic Dermatitis Candidate ASLAN004)?

    The current valuation of CSL (Atopic Dermatitis Candidate ASLAN004) is .

  • What is CSL (Atopic Dermatitis Candidate ASLAN004)’s current revenue?

    The current revenue for CSL (Atopic Dermatitis Candidate ASLAN004) is .

  • Who are CSL (Atopic Dermatitis Candidate ASLAN004)’s investors?

    CSL has invested in CSL (Atopic Dermatitis Candidate ASLAN004).

  • When was CSL (Atopic Dermatitis Candidate ASLAN004) acquired?

    CSL (Atopic Dermatitis Candidate ASLAN004) was acquired on 31-May-2019.

  • Who acquired CSL (Atopic Dermatitis Candidate ASLAN004)?

    CSL (Atopic Dermatitis Candidate ASLAN004) was acquired by ASLAN Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process